Na. Scott et al., Inhibition of vascular cell growth by X-ray irradiation: Comparison with gamma radiation and mechanism of action, INT J RAD O, 50(2), 2001, pp. 485-493
Citations number
40
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: Catheter-based delivery of gamma and beta radiation effectively in
hibits restenosis. Major disadvantages of these radioisotopes include conti
nuous emission; excessive depth of penetration, creating safety hazards (ga
mma); and inadequate penetration, limiting effectiveness (beta). Low-voltag
e X-rays have a distinct potential advantage, because the source is active
only when current is applied, and depth of penetration is voltage dependent
. This study was performed to determine if low-voltage X-rays inhibit smoot
h muscle and adventitial cell growth in vitro and to determine the molecula
r mechanisms involved in this cellular response.
Methods and Results: Vascular cells in culture were exposed to low-voltage
X-ray radiation and analyzed for their subsequent ability to proliferate. X
-ray irradiation caused a dose-dependent inhibition in proliferation, simil
ar to the effect seen with equivalent doses of gamma radiation. The radiati
on-induced inhibition of proliferation did not appear to be related to apop
tosis, but rather to delayed progression through the cell cycle, because a
65% increase in the proportion of cells in S phase was seen 24-96 h after X
-ray exposure compared to control. Expression of p53, a cell cycle transcri
ptional activator, and p21, a cell cycle inhibitor, were significantly elev
ated after exposure to low-voltage X-rays, providing a potential mechanism
for this delay.
Conclusions: Low-voltage X-rays can effectively inhibit proliferation of va
scular smooth muscle and adventitial cells. This inhibition is apparently d
ue to a delay in progression through the cell cycle, which is mediated by i
ncreases in the levels of cell cycle inhibitors. (C) 2001 Elsevier Science
Inc.